sábado, 14 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 15, 2026

Applied Materials Q2 Earnings Beat Estimates, Revenues Increase Y/Y

View original at finance.yahoo.com
Applied Materials Q2 Earnings Beat Estimates, Revenues Increase Y/Y Applied Materials AMAT reported second-quarter fiscal 2026 non-GAAP earnings of $2.86 per share, which beat the Zacks Consensus Estimate by 6.5%…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • EPIC platform is designed to shorten commercialization cycles from research to full-scale manufacturing

    60% confidence
  • Applied Materials has more than 35,000 users across its global workforce adopting AI internally

    60% confidence
  • AI demand is expanding beyond training and inference into agentic applications, which are more CPU-intensive and can raise demand for DRAM and NAND

    60% confidence
  • EPIC collaboration model will improve R&D productivity, increase multi-node visibility for investment decisions, and accelerate design wins for tools and services

    60% confidence
  • Quarter strength driven by the rapid global build-out of AI computing infrastructure and Applied Materials' leadership in leading-edge foundry-logic, DRAM and advanced packaging

    60% confidence
  • Largest customers are providing rolling eight-quarter forecasts, supporting planning for capacity and service resources

    60% confidence
  • The EPIC Center in Silicon Valley remains on track to begin operations in the fall

    60% confidence

Data points we hold from this source

Applied Materials, Inc. · eps2.86 USD
Applied Materials, Inc. · average earnings surprise7.1 percent
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Applied Materials Q2 Earnings Beat Estimates, Revenues Increase Y/Y — Source | Via News | pt.VIA.NEWS